HUB offers you a very innovative position as part of a professional and internationally oriented, fast growing, organization. Our expansion brings new and interesting challenges in the coming years which will support the implementation of new and innovative Organoid models and services. The Director’s role is a new position within HUB which will be leading a service oriented department for our drug development and screening platform. You will closely collaborate with the research and operation directors, as well as sales and marketing, to help further implement and optimize our technology.
If you are interested, we invite you to respond before 1st July 2021. You can send your resume and covering letter to email@example.com. For more information please contact CSO Sylvia Boj or CEO Robert Vries by phone on +31(0)88 1236300 during office hours.
HUB is an innovative research and service oriented international company. Hubrecht Organoid Technology (HUB) was founded by the Hubrecht Institute, the University Medical Center Utrecht, and the Royal Netherlands Academy of Arts and Sciences (KNAW) to refine organoid development and foster organoid adoption globally. HUB Organoid Technology represents a paradigm-shift that bridges the gap between the lab and the clinic and effectively brings “patients in the lab” for drug discovery and development, preclinical patient stratification, predictive biomarker discovery, personalized medicine, clinical trials, regenerative medicine, and companion diagnostics applications.apply now